Implantation of a Poly-l-Lactide GCSF-Functionalized Scaffold in a Model of Chronic Myocardial Infarction Academic Article uri icon


MeSH Major

  • Drug Carriers
  • Fibroblasts
  • Filgrastim
  • Myocardial Infarction
  • Myocardium
  • Polyesters


  • A previously developed poly-L-lactide scaffold releasing granulocyte colony-stimulating factor (PLLA/GCSF) was tested in a rabbit chronic model of myocardial infarction (MI) as a ventricular patch. Control groups were constituted by healthy, chronic MI and nonfunctionalized PLLA scaffold. PLLA-based electrospun scaffold efficiently integrated into a chronic infarcted myocardium. Functionalization of the biopolymer with GCSF led to increased fibroblast-like vimentin-positive cellular colonization and reduced inflammatory cell infiltration within the micrometric fiber mesh in comparison to nonfunctionalized scaffold; PLLA/GCSF polymer induced an angiogenetic process with a statistically significant increase in the number of neovessels compared to the nonfunctionalized scaffold; PLLA/GCSF implanted at the infarcted zone induced a reorganization of the ECM architecture leading to connective tissue deposition and scar remodeling. These findings were coupled with a reduction in end-systolic and end-diastolic volumes, indicating a preventive effect of the scaffold on ventricular dilation, and an improvement in cardiac performance.

publication date

  • February 2017



  • Academic Article



  • eng

PubMed Central ID

  • PMC5323505

Digital Object Identifier (DOI)

  • 10.1007/s12265-016-9718-9

PubMed ID

  • 28116550

Additional Document Info

start page

  • 47

end page

  • 65


  • 10


  • 1